CTOs on the Move

Virpax Pharmaceuticals

www.virpaxpharma.com

 
Virpax`s lead product candidate, Probudur, is being developed using our proprietary liposomal encapsulation to deliver a sustain release of local anesthetic at the wound/incision site to control post-operative pain for 96 hours. We have executed Cooperative Research and Development Agreements (CRADA), as well as the National Institute of Health/NCATS; U.S. Army Institute of Surgical Research/Department of Defense to develop differentiated non-addictive treatment options and the Epilepsy Therapy Screening Program (ETSP) which is focused on focused on addressing drug resistant epilepsy, disease prevention and modification. The three products in development are targeting unmet global needs in three separate multi-billion-dollar markets, including ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Virpax Pharmaceuticals raised $18M on 02/16/2021

Similar Companies

Ivantis

Help control your eye pressure and possibly reduce your need for Glaucoma medication with the Hydrus® Microstent.

Triax Pharmaceuticals

Triax Pharmaceuticals is a Cranford, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Components

Dialysis and Vascular Access Products

Bioheart

Founded in 1999, Bioheart, Inc. is committed to the development of effective cell technologies to treat cardiovascular diseases.

R.D. Laboratories

R.D. Laboratories is a Washington, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.